Studies have shown that TPM1 can increase the sensitivity of colon cancer cells to chemotherapy drugs and can exert an inhibitory effect on colon cancer cells [60], which is consistent with our findings. This evidence concerns the gene TPM1 and malignant colon neoplasm.